Vifor Pharma to acquire Inositec
22.11.2021
Vifor Pharma has announced the acquisition of Inositec AG, a Swiss start-up, developing first-in-class non-dialysis treatments for soft tissue and vascular calcification disorders. Inositec purchase price includes an upfront payment of CHF 20 million and success based clinical earn-out payments.